Lazard LAZ Stock Undervalued vs Peers Slight Gain 20260418 VYNE Therapeutics Inc VYNE reports narrower Q4 2025 loss than estimates yet shares dip slightly in todays trading EVI Industries Inc EVI slides 406 after Q1 2026 EPS miss despite 103 percent year over year revenue growth First FCBC Q1 EPS misses estimates by 06 percent yet revenue growth lifts FCBC shares 062 percent Antero Resources Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Declines GROY Q1 2026 Earnings Slight EPS Miss Amidst Quiet Quarter High Tide Inc Q1 2026 Earnings EPS Surges Past Estimates by 300 MDLZ Q1 2026 Earnings EPS Surpasses Estimates as Profitability Drives Performance DCTH Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Progress Heartbeam Inc BEAT Q1 2026 Earnings EPS Surprises to the Upside Amid Revenue Data Absence